Results 141 to 150 of about 263,626 (317)

Additional file 1: Box S1. of Guidelines for dementia or Parkinsonâ s disease with depression or anxiety: a systematic review

, 2016
Search Strategy. (DOCX 22Â kb)
Goodarzi, Zahra, Mele, Bria, Guo, Selynne, Hanson, Heather, Jette, Nathalie, Patten, Scott, Pringsheim, Tamara, Holroyd-Leduc, Jayna   +7 more
openaire   +1 more source

Blood metabolomics profiling of Parkinson’s disease reveals coordinated pathway alterations [PDF]

FNR14599012 - Validating Digital Biomarkers For Better Personalized Treatment Of Parkinson’s Disease, 2020 (01/05/2021-30/04/2024) - Enrico Glaab3.
GLAAB, Enrico
core  

Cognitive impairment in Parkinson's disease : is it a unified phenomenon?

, 2005
Parkinson's disease (PD) has long been associated with dementia. This has been found to correlate with participant age, age at onset of PD and severity of PD.
Lowit, Anja, Anja Lowit, Howell, Peter, Peter Howell, Brendel, Bettina, Bettina Brendel   +5 more
core   +1 more source

Sex‐Stratified Association of Regional Dopamine Transporter Binding With Disease Progression in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe, Keizo Sugaya, Kentaro Hayashi, Keiko Hino, Yasuhiro Nakata, Kota Bokuda, Toshio Shimizu, Kazushi Takahashi   +7 more
wiley   +1 more source

Additional file 2: Table S1. of Guidelines for dementia or Parkinsonâ s disease with depression or anxiety: a systematic review

, 2016
Grey Literature Sources (n = 83). (DOCX 15 kb)
Goodarzi, Zahra, Mele, Bria, Guo, Selynne, Hanson, Heather, Jette, Nathalie, Patten, Scott, Pringsheim, Tamara, Holroyd-Leduc, Jayna   +7 more
openaire   +1 more source

A Two‐Stage Questionnaire and Actigraphy Screening for iRBD in a Multicenter Retrospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid‐eye‐movement sleep behavior disorder is a prodromal marker of synucleinopathies. However, most cases remain undiagnosed due to the insufficient predictive value of questionnaires and limited access to confirmatory video‐polysomnography. We assessed a two‐stage screening strategy combining a brief questionnaire on rapid‐
Caleb A. Massimi, Giorgio Ricciardiello Mejia, Andre Metzger, Kang Hyun Ryu, Salonee Marwaha, Eva Grzegorczyk, Li Zhou, Eliana Jacobs, Boris Gilyadov, Claudia Kunney, Liqhwa Ncube, Ankit Parekh, Emmanuel Mignot, Fanny M. Elahi, Joseph Winer, Kathleen Poston, Andreas Brink‐Kjaer, Emmanuel H. During   +17 more
wiley   +1 more source

Driving impairment in patients with movement disorders: examining the Baylor driving questionnaire by objective driving assessment

Clinical Parkinsonism & Related Disorders
Background: The development of a screening tool to identify driving impairment in patients with movement disorders is an unmet need. Objective: To validate Baylor Driving Questionnaire for Movement Disorders (BDQMD) by objective driving assessment (ODA).
Abhishek Lenka, Ruosha Li, Karim Makhoul, Alan Gonzalez, Rory D. Mahabir, Joseph Jankovic   +5 more
doaj   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers, Yaqiao Wei, Dinesh K. Deelchand, Adam Berrington, Young Woo Park, Guita Banan, Michal Povazan, Jens T. Rosenberg, André J. W. van der Kouwe, Tetsuo Ashizawa, Khalaf O. Bushara, Chiadi U. Onyike, Sub H. Subramony, Jeremy D. Schmahmann, Brian J. Soher, Peter B. Barker, Thomas H. Mareci, Eva‐Maria Ratai, Lynn E. Eberly, Gülin Öz   +19 more
wiley   +1 more source

Additional file 1 of Altered gut microbiota and inflammatory cytokine responses in patients with Parkinsonâ s disease

, 2019
: Supplementary methods. (DOCX 21 kb)
Lin, Chin-Hsien, Chen, Chieh-Chang, Chiang, Han-Lin, Liou, Jyh-Ming, Chang, Chih-Min, Lu, Tzu-Pin, Chuang, Eric, Tai, Yi-Cheng, Cheng, Chieh, Lin, Han-Yi, Wu, Ming-Shiang   +10 more
openaire   +1 more source

Biomarkers of Parkinson’s disease

, 2012
Biomarkers for Parkinson’s disease (PD) are absolutely needed both to achieve an early/differential diagnosis and to find disease-modifying treatments.
FASANO, MAURO, ALBERIO, TIZIANA
core